---
schema_version: "secwatch.filing_event.v1"
accession: "0001412408-23-000017"
form_type: "8-K"
ticker: "PHR"
cik: "0001412408"
company_name: "Phreesia, Inc."
filed_at: "2023-03-22T23:59:59+00:00"
generated_at: "2026-06-17T21:12:08.000634+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Phreesia Q4 FY2023 revenue $76.6M (+32% YoY); FY2024 guidance revenue $353-356M

## Summary
- Q4 revenue $76.6M (+32% YoY); net loss $38.0M vs $46.5M loss year ago; Adj. EBITDA -$17.6M vs -$30.5M.
- AHSCs 3,140 (+36% YoY); Healthcare services revenue per AHSC $17,705 (-4% YoY).
- Full year revenue $280.9M (+32%); net loss $176.1M vs $118.2M prior year; Adj. EBITDA -$92.5M.
- FY2024 outlook: revenue $353-356M (26-27% growth); Adj. EBITDA loss -$65M to -$60M (improvement).
- Cash $176.7M at Jan 31; transferred funds from SVB on March 9 before FDIC receivership; all cash available.

## SEC filing metadata
- accession: 0001412408-23-000017
- form_type: 8-K
- ticker: PHR
- cik: 0001412408
- company_name: Phreesia, Inc.
- filed_at: 2023-03-22T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/phr-20230322.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001412408-23-000017
- JSON: https://secwatch.observer/filing/0001412408-23-000017.json
- Plain text: https://secwatch.observer/filing/0001412408-23-000017.txt

## Key facts
- Earnings Releases
  Phreesia, Inc. reported FY2024 ending January 31, 2024 results: revenue $353 million to $356 million. Guidance initiated.
  - Period: FY2024 ending January 31, 2024
  - Revenue: $353 million to $356 million
  - Guidance: initiated
  - Result: guidance update
  source text: For the full fiscal year 2024 ending January 31, 2024, we expect revenue to be between $353 million and $356 million, implying year-over-year growth of 26% to 27%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm
- Earnings Releases
  Phreesia, Inc. reported Q4 FY2023 ended January 31, 2023 results: revenue $76.6 million, net income $38.0 million.
  - Period: Q4 FY2023 ended January 31, 2023
  - Revenue: $76.6 million
  - Net income: $38.0 million
  - Result: reported results
  source text: • Revenue was $76.6 million in the quarter, up 32% year-over-year. • Average number of healthcare services clients ("AHSCs") was 3,140 in the quarter, up 36% year-over-year. • Healthcare services revenue per AHSC was $17,705 in the quarter, down 4% year-over-year. The decline was primarily driven by healthcare services client growth significantly outpacing growth in payment processing volume and payment processing revenue. See "Key Metrics" below for additional information. • Total revenue per AHSC was $24,390 in the quarter, down 3% year-over-year. The decline was primarily driven by healthcare services client growth significantly outpacing growth in payment processing volume and payment processing revenue. See "Key Metrics" below for additional information. • Net loss was $38.0 million in the quarter compared to $46.5 million in the same period in the prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1412408/000141240823000017/0001412408-23-000017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.